Statistics
Publications
2
Citations
47
H-Index
2
Active since
2017
Affiliations
He Wenjing is an author at First Affiliated Hospital of Nanchang University specializing in cell signaling, pharmacology, and signal transduction.
Publications per year
2017–2020
2
2
Exendin‐4 enhances the sensitivity of prostate cancer to enzalutamide by targeting Akt activation
He Wenjing, Yuanyuan Shao, Yi Yu et al. · The Prostate · 2020 · 28 citations
Medicine, Oncology, Pharmacology +15
Exendin-4 does not modify growth or apoptosis of human colon cancer cells
He Wenjing, Shuang Yu, Li Weisong et al. · Endocrine Research · 2017 · 19 citations
1–2 of 2